These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 17443723)

  • 1. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.
    Ngan CY; Yamamoto H; Seshimo I; Ezumi K; Terayama M; Hemmi H; Takemasa I; Ikeda M; Sekimoto M; Monden M
    J Surg Oncol; 2007 Jun; 95(8):652-62. PubMed ID: 17443723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
    Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
    J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas.
    Masaki T; Sugiyama M; Matsuoka H; Abe N; Izumisato Y; Goto A; Sakamoto A; Atomi Y
    J Gastroenterol; 2003; 38(1):37-44. PubMed ID: 12560920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of CD44 expression in colorectal carcinomas.
    Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
    Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
    Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy.
    Aschele C; Debernardis D; Lonardi S; Bandelloni R; Casazza S; Monfardini S; Gallo L
    J Clin Oncol; 2004 Sep; 22(18):3758-65. PubMed ID: 15365072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma.
    Roca F; Mauro LV; Morandi A; Bonadeo F; Vaccaro C; Quintana GO; Specterman S; de Kier Joffé EB; Pallotta MG; Puricelli LI; Lastiri J
    J Surg Oncol; 2006 Feb; 93(2):151-60. PubMed ID: 16425303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer.
    Kwak JM; Min BW; Lee JH; Choi JS; Lee SI; Park SS; Kim J; Um JW; Kim SH; Moon HY
    Dis Colon Rectum; 2007 Nov; 50(11):1873-80. PubMed ID: 17828401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
    Gal R; Sadikov E; Sulkes J; Klein B; Koren R
    Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma.
    Setoyama T; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Yokomakura N; Ishigami S; Aikou T
    J Surg Oncol; 2007 Feb; 95(2):148-55. PubMed ID: 17262732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
    Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
    Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
    Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
    Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK
    Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Takeuchi T; Kitamura T
    Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis.
    Saito T; Masuda N; Miyazaki T; Kanoh K; Suzuki H; Shimura T; Asao T; Kuwano H
    Oncol Rep; 2004 Mar; 11(3):605-11. PubMed ID: 14767510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].
    Qiao GB; Wu YL; Ou W; Yang XN; Zhong WZ; Lin JY; Zhao J; Xie D; Guan XY
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):913-7. PubMed ID: 16083620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
    Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
    Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.